Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLSIA (Premier Laser Systems) -- Ignore unavailable to you. Want to Upgrade?

To: WTMHouston who wrote (1421)	12/21/1997 11:19:00 AM
From: kvogel	Read Replies (1) \| Respond to of 1773

Troy, PLSIA is hard to evaluate by normal standards since the company is in its infancy. This has led to many projections which are pure speculation ( both positive and negative). The main reason I like PLSIA is that it has been able to raise enough money to pursue its growth at a quick pace. It takes money to do clinical trials required to get backing by the FDA, do promotions, go to trade shows, and set up good production facilities. This is the area where PLSIA has a great advantage over ADLI and BLTI which are more cash strapped. It is clear to me that new technology using lasers for eyes, teeth, and skin will be a part of medicine for the 21st century. How these systems are used and final configurations will be an evolving process but PLSIA will be a leader and already has inroads with the FDA. Look for better things to come. This is my opinion with no more facts than you have. Karl